Top Warren Buffett Stocks To Own Right Now

When stock markets turn volatile many investors find it difficult to stay the course. Some investors want to sell off and want to hoard their cash. Some prefer to start buying the stocks that are falling the most. But such knee-jerk reactions may not create wealth for you. Here are five thoughts of Warren Buffett that may guide you in your investment actions in such volatile times.

It’s far better to buy a wonderful company at a fair price than a fair company at a wonderful price.

Quality matters. Just because a company has fallen 20% from its 52 week high does not make it a great value buy. Do check the fundamentals of the company. Corrections in the market must be used to buy quality stocks for your long term portfolio. Buying them at a fair price makes sense for long term investors. Good businesses tend to compound their profits and reward the shareholders in the long term. Stick to companies that have exhibited decent business performance across business cycles.

Picking up the micro-cap stocks with great potentials may not reward you if the stories do not materialise as expected. If you have a dud stock in your portfolio, use the spikes to get rid of it. Use the proceeds to buy fundamentally strong companies.

Top Warren Buffett Stocks To Own Right Now: Universal Stainless & Alloy Products, Inc.(USAP)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Universal Stainless & Alloy Products (USAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) traded down 0% on Friday . The company traded as low as $24.22 and last traded at $24.53. 505,097 shares were traded during trading, an increase of 1,278% from the average session volume of 36,661 shares. The stock had previously closed at $24.53.

  • [By Ethan Ryder]

    Universal Stainless & Alloy Products (NASDAQ: USAP) and SUMITOMO Corp/S (OTCMKTS:SSUMY) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Top Warren Buffett Stocks To Own Right Now: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about PDC Energy (NASDAQ:PDCE) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PDC Energy earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the energy producer an impact score of 46.6251700229584 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Warren Buffett Stocks To Own Right Now: Sandy Spring Bancorp, Inc.(SASR)

Advisors’ Opinion:

  • [By Max Byerly]

    MetLife Investment Advisors LLC lifted its holdings in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 38.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,587 shares of the bank’s stock after buying an additional 4,054 shares during the period. MetLife Investment Advisors LLC’s holdings in Sandy Spring Bancorp were worth $565,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    LSV Asset Management cut its stake in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 3.4% in the 1st quarter, Holdings Channel reports. The fund owned 92,100 shares of the bank’s stock after selling 3,200 shares during the quarter. LSV Asset Management’s holdings in Sandy Spring Bancorp were worth $3,569,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    Maltese Capital Management LLC raised its position in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 230.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 330,712 shares of the bank’s stock after acquiring an additional 230,611 shares during the quarter. Maltese Capital Management LLC owned approximately 0.93% of Sandy Spring Bancorp worth $12,818,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Joseph S. Bracewell sold 32,173 shares of the stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $43.36, for a total transaction of $1,395,021.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

  • [By Shane Hupp]

    News articles about Sandy Spring Bancorp (NASDAQ:SASR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sandy Spring Bancorp earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave news headlines about the bank an impact score of 44.8977197847726 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Stephan Byrd]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Mark C. Michael sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $41.30, for a total value of $41,300.00. Following the transaction, the director now directly owns 81,590 shares of the company’s stock, valued at $3,369,667. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Top Warren Buffett Stocks To Own Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    After clinical-stage competitor Loxo Oncology (NASDAQ:LOXO) presented impressive data at the American Society of Clinical Oncology (ASCO) meeting this weekend, shares in Blueprint Medicines (NASDAQ:BPMC) tumbled by as much as 16% on Monday.

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Ethan Ryder]

    Northern Trust Corp boosted its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 0.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 497,135 shares of the biotechnology company’s stock after acquiring an additional 726 shares during the period. Northern Trust Corp owned 1.13% of Blueprint Medicines worth $45,588,000 at the end of the most recent quarter.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

Leave a Reply

Your email address will not be published. Required fields are marked *